The markets ended the day mixed with the Dow closing flat at 16,501 while the tech heavy Nasdaq gained 21 points to 4,148 on strong earnings from Apple.

On the upside 

Reuters reported that Elizabeth Arden (Nasdaq: RDEN) retained the services of Goldman Sachs to explore a potential sale of the cosmetics company.

VASCO Data Security International (Nasdaq: VDSI) reported higher first quarter earnings and revenue.

Ultratech (Nasdaq: UTEK) fell to a loss for the first quarter but the company expects a stronger second half of the year.

On the downside 

Parametric Sound (Nasdaq: HEAR) priced its public offering of 4 million common shares at the discounted price of $10.00 per share.

Clearfield (Nasdaq: CLFD) reported sharply higher second quarter earnings and revenue but the results fell short of analyst expectations.

Tsakos Energy Navigation (NYSE: TNP) priced its public offering of 11 million common shares at the discounted price of $7.30 per share.

In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners outpaced advancers by 7 to 5 on Nasdaq. The broader S&P 500 added 3 points to 1878. Bitcoin rose $4.29 or 0.88% to $489.95.

Markets Advance At Midday

|

The markets advanced during the midday with the Dow rising 15 points to 16,517. Nasdaq gained 27 points to 4,154.

On the upside 

First quarter earnings slipped for Citrix Systems (Nasdaq: CTXS) but the results were better than expected and the company increased its stock repurchase program by $1.5 billion.

Maxim Group initiated coverage of Cesca Therapeutics (Nasdaq: KOOL) with a Buy rating.

D.R. Horton (NYSE: DHI) reported higher second quarter earnings and revenue that topped analyst expectations.

On the downside 

Fusion-io (NYSE: FIO) widened losses for the third quarter even as revenue rose.

First quarter earnings plunged for Ingram Micro (NYSE: IM) to fall short of analyst expectations.

Eagle Rock Energy Partners (Nasdaq: EROC) suspended its quarterly cash distribution prompting Bank of America to lower its price target on the company from $6.50 to $5.50.

In the broad market, advancing issues outpaced decliners by a margin of 9 to 7 on the NYSE while decliners edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 rose 5 points to 1881. Bitcoin slipped $1.48 or 0.31% to $484.18.

Upbeat earnings lifted the markets to a higher open with the Dow adding a point to 16,503 Nasdaq rose 12 points to 4,139.

On the upside 

Zimmer Holdings (NYSE: ZMH) will pay approximately $13.35 billion in cash and stock to acquire Biomet.

Apple (Nasdaq: AAPL) reported higher second quarter earnings that topped analyst estimates, increased its stock repurchase program and announced a 7-for-1 stock split.

Third quarter earnings surged for Lam Research (Nasdaq: LRCX) to beat analyst expectations and the company forecast current quarter earnings ahead of estimates.

On the downside 

Xilinx (Nasdaq: XLNX) reported higher fourth quarter earnings but the results missed expectations.

First quarter earnings surged for Under Armour (NYSE: UA) to top analyst estimates but the stock price fell.

ServiceNow (NYSE: NOW) widened first quarter losses even as revenue surged.

In the broad market, declining issues outpaced advancers by a margin of nearly 9 to 7 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 edged up a point to 1876. Bitcoin eased $0.66 or 0.14% to $485.00.

Plunging new home sales weighed the markets down to a lower close with the Dow slipping 12 points to 16,501. Nasdaq tumbled 34 points to 4,126.

On the upside 

Second quarter earnings slipped for Sanmina (Nasdaq: SANM) but the results were better than expected and the company forecast current quarter earnings ahead of estimates.

The final arbitration ruling in Hugoton Royalty Trust's (NYSE: HGT) proceedings against XTO Energy favored Hugoton Royalty Trust.

South Korean cosmetics company LG Household may explore purchasing Elizabeth Arden (Nasdaq: RDEN).

On the downside 

Unisys (NYSE: UIS) widened first quarter losses as revenue slipped.

Noranda Aluminum (NYSE: NOR) fell to a greater than expected loss for the first quarter as revenue dropped.

Zix (Nasdaq: ZIXI) reported higher first quarter earnings and revenue but the company forecast current quarter results below expectations.

In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 slipped 4 points to 1875. Bitcoin edged up $0.17 or 0.04% to $483.30.

The markets traded lower during the midday with the Dow losing 10 points to 16,503 as new home sales plummeted in March. Nasdaq fell 24 points to 4,136.

On the upside 

Israeli business newspaper Globes reported that Starbucks (Nasdaq: SBUX) engaged in discussions to acquire a 10% stake in SodaStream International (Nasdaq: SODA).

Shares of GW Pharmaceuticals (Nasdaq: GWPH) continued rising after Morgan Stanley set a $103 price target on the medical marijuana company yesterday.

Xoom (Nasdaq: XOOM) reversed year ago losses to post a stronger than expected profit for the first quarter as revenue surged.

On the downside 

Zhone Technologies (Nasdaq: ZHNE) disappointed with flat first quarter earnings and revenue.

First quarter earnings tumbled for iRobot (Nasdaq: IRBT).

Intuitive Surgical (Nasdaq: ISRG) reported sharply lower first quarter earnings and revenue.

In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while decliners edged out advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 eased a point to 1878. Bitcoin slipped $1.66 or 0.34% to $481.48.

New home sales plunged in March to weigh the markets down to a lower open with the Dow slipping 11 points to 16,502. Nasdaq lost 21 points to 4,139.

On the upside 

Skyworks Solutions (Nasdaq: SWKS) reported higher second quarter earnings and revenue that topped analyst estimates and forecast current quarter results ahead of expectations.

Supervalu (NYSE: SVU) swung to a stronger than expected profit for the fourth quarter as revenue rose.

Cognex (Nasdaq: CGNX) received two purchase orders valued at more than $40 million.

On the downside 

Cree (Nasdaq: CREE) reported higher third quarter earnings and revenue but gross margin slipped.

Third quarter earnings and revenue rose for VMware (NYSE: VMW) but a number of enterprise license agreements were delayed.

International Game Technology (NYSE: IGT) reported sharply lower second quarter earnings as revenue fell.

In the broad market, advancing issues were on par with decliners on the NYSE while decliners outpaced advancers by more than 5 to 3 on Nasdaq. The broader S&P 500 eased a point to 1877. Bitcoin slipped $1.70 or 0.35% to $481.44.

Merger news along with strong earnings lifted the markets to a higher
close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points
to 4,161.
 
On the upside
 
Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside


A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.
Merger news along with strong earnings lifted the markets to a higher
close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points
to 4,161.
 
On the upside
 
Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside


A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Higher Close On Strong Earnings

|

Merger news along with strong earnings lifted the markets to a higher close with the Dow gaining 65 points to 16,514. Nasdaq climbed 39 points to 4,161.

On the upside 

Revance Therapeutics (Nasdaq: RVNC) reported positive results from a Phase 1/2 study of its injectable frown line treatment RT002.

Brean Capital initiated coverage of SunEdison (NYSE: SUNE) with a Hold rating while Greenlight Capital disclosed that it acquired a large position in the company.

Jefferies Group initiated coverage of Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and a $15 price target.

On the downside 

A Seeking Alpha contributor reminded investors that Unilife (Nasdaq: UNIS) has been the target of an ongoing law enforcement investigation.

Zacks Small Cap Research said that investors should not own DARA BioSciences (Nasdaq: DARA).

Investors locked in profits on Abraxas Petroleum (Nasdaq: AXAS).

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 rose 7 points to 1879. Bitcoin slipped $2.80 or 0.58% to $485.70.

Powered by Movable Type 5.12